ARP19_HUMAN - dbPTM
ARP19_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARP19_HUMAN
UniProt AC P56211
Protein Name cAMP-regulated phosphoprotein 19
Gene Name ARPP19
Organism Homo sapiens (Human).
Sequence Length 112
Subcellular Localization Cytoplasm.
Protein Description Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at Ser-62 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase. May indirectly enhance GAP-43 expression..
Protein Sequence MSAEVPEAASAEEQKEMEDKVTSPEKAEEAKLKARYPHLGQKPGGSDFLRKRLQKGQKYFDSGDYNMAKAKMKNKQLPTAAPDKTEVTGDHIPTPQDLPQRKPSLVASKLAG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1 (in isoform 2)Acetylation-8.48-
2Phosphorylation------MSAEVPEAA
------CCCCCCCCC
32.8925159151
2Acetylation------MSAEVPEAA
------CCCCCCCCC
32.8919413330
6 (in isoform 2)Phosphorylation-19.6025849741
7 (in isoform 2)Phosphorylation-63.1425849741
10PhosphorylationAEVPEAASAEEQKEM
CCCCCCCCHHHHHHH
43.1725159151
22PhosphorylationKEMEDKVTSPEKAEE
HHHHHHCCCHHHHHH
44.2829255136
23PhosphorylationEMEDKVTSPEKAEEA
HHHHHCCCHHHHHHH
33.7729255136
26AcetylationDKVTSPEKAEEAKLK
HHCCCHHHHHHHHHH
65.5619608861
31AcetylationPEKAEEAKLKARYPH
HHHHHHHHHHHHCCC
54.527709657
33AcetylationKAEEAKLKARYPHLG
HHHHHHHHHHCCCCC
30.0618604429
35MethylationEEAKLKARYPHLGQK
HHHHHHHHCCCCCCC
43.88-
36PhosphorylationEAKLKARYPHLGQKP
HHHHHHHCCCCCCCC
10.40-
42 (in isoform 2)Ubiquitination-43.7821890473
42AcetylationRYPHLGQKPGGSDFL
HCCCCCCCCCCCHHH
43.7823749302
42UbiquitinationRYPHLGQKPGGSDFL
HCCCCCCCCCCCHHH
43.78-
46PhosphorylationLGQKPGGSDFLRKRL
CCCCCCCCHHHHHHH
30.9825159151
58UbiquitinationKRLQKGQKYFDSGDY
HHHHHCCCHHCCCCH
57.4621890473
58 (in isoform 1)Ubiquitination-57.4621890473
58AcetylationKRLQKGQKYFDSGDY
HHHHHCCCHHCCCCH
57.4688691
59PhosphorylationRLQKGQKYFDSGDYN
HHHHCCCHHCCCCHH
12.5322167270
62PhosphorylationKGQKYFDSGDYNMAK
HCCCHHCCCCHHHHH
24.5419664994
65PhosphorylationKYFDSGDYNMAKAKM
CHHCCCCHHHHHHHH
15.4625463755
69UbiquitinationSGDYNMAKAKMKNKQ
CCCHHHHHHHHCCCC
37.462189047
71UbiquitinationDYNMAKAKMKNKQLP
CHHHHHHHHCCCCCC
50.10-
79PhosphorylationMKNKQLPTAAPDKTE
HCCCCCCCCCCCCCC
44.0020068231
84AcetylationLPTAAPDKTEVTGDH
CCCCCCCCCCCCCCC
45.5925953088
85PhosphorylationPTAAPDKTEVTGDHI
CCCCCCCCCCCCCCC
42.9726074081
88PhosphorylationAPDKTEVTGDHIPTP
CCCCCCCCCCCCCCC
30.5726074081
94PhosphorylationVTGDHIPTPQDLPQR
CCCCCCCCCCCCCCC
32.7426074081
94O-linked_GlycosylationVTGDHIPTPQDLPQR
CCCCCCCCCCCCCCC
32.74OGP
102UbiquitinationPQDLPQRKPSLVASK
CCCCCCCCHHHHHHH
33.44-
104PhosphorylationDLPQRKPSLVASKLA
CCCCCCHHHHHHHHC
38.2123401153
108PhosphorylationRKPSLVASKLAG---
CCHHHHHHHHCC---
22.2623927012
109AcetylationKPSLVASKLAG----
CHHHHHHHHCC----
32.3919608861

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
46SPhosphorylationKinaseMAST3O60307
PSP
62SPhosphorylationKinaseMASTLQ96GX5
PSP
104SPhosphorylationKinasePKACAP17612
PSP
104SPhosphorylationKinasePKG1Q13976
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
62SPhosphorylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARP19_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARP19_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-109, AND MASS SPECTROMETRY.

TOP